However, in cases of intermediate PSA levels, it is difficult to discriminate between prostate cancer and BPH, particularly in patients with PSA levels between 2.6 and 10.0 ng/mL, in which there is an overlap between the two conditions (5). Here, KLK3 is linked to prostate carcinoma.